AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.83
-0.04 (-0.37%)
At close: Mar 6, 2026, 4:00 PM EST
10.80
-0.03 (-0.28%)
After-hours: Mar 6, 2026, 7:35 PM EST
AngioDynamics Revenue
AngioDynamics had revenue of $79.43M in the quarter ending November 30, 2025, with 9.04% growth. This brings the company's revenue in the last twelve months to $307.31M, up 7.26% year-over-year. In the fiscal year ending May 31, 2025, AngioDynamics had annual revenue of $292.50M, down -3.76%.
Revenue (ttm)
$307.31M
Revenue Growth
+7.26%
P/S Ratio
1.45
Revenue / Employee
$455,268
Employees
675
Market Cap
446.38M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 292.50M | -11.42M | -3.76% |
| May 31, 2024 | 303.91M | -34.84M | -10.28% |
| May 31, 2023 | 338.75M | 22.53M | 7.13% |
| May 31, 2022 | 316.22M | 25.21M | 8.66% |
| May 31, 2021 | 291.01M | 26.85M | 10.17% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Embecta | 1.08B |
| Azenta | 595.03M |
| STAAR Surgical Company | 239.44M |
| OraSure Technologies | 115.02M |
| Sanara MedTech | 101.88M |
| BioLife Solutions | 96.21M |
| KORU Medical Systems | 39.07M |
| Utah Medical Products | 38.52M |
ANGO News
- 12 days ago - AngioDynamics to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 16 days ago - AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform - Business Wire
- 4 weeks ago - AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care - Business Wire
- 4 weeks ago - AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance - Business Wire
- 7 weeks ago - AngioDynamics, Inc. (ANGO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AngioDynamics, Inc. (ANGO) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 2 months ago - AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability - Business Wire
- 2 months ago - AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga